Our study accord with a pathogenic BRCA1 mutation: p.Ile1845fs and identified 94 carriers (0.40%) in 23,481 breast cancer patients, and 11 (0.17%, 11/6489) in controls. Here, BRCA1 is linked to breast cancer.